Upcoming IPO: Hexagon Nutrition's public offer opens next week; check price band, lot size and key dates

Upcoming IPO: After a long dry spell in the mainboard IPO market, Hexagon Nutrition Ltd is set to launch its initial public offering (IPO) on June 5, 2026, with the issue closing on June 9, 2026. The public offer is a book-built issue worth Rs 138.87 crore and consists entirely of an offer for sale (OFS), meaning no fresh capital will be raised for the company.

Since the issue is fully an OFS, all proceeds will go directly to the selling shareholders. According to the company's red herring prospectus (RHP) Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Aditya Kelkar, and Nutan Subhash Kelkar, are the selling shareholders divesting part of their stake. The company itself will not receive any funds from the IPO.

IPO price band and lot size

The price band for the issue has been fixed at Rs 42–Rs 45 per share, and the implied market capitalisation stands at around Rs 553.13 crore. The IPO comprises 3.09 crore equity shares.

Investors can bid in a lot size of 333 shares and in multiples thereof. For retail investors, this translates to a minimum investment of Rs 14,985 at the upper price band.

IPO anchor investment and key dates

The IPO's anchor investment date is fixed on June 4, 2026, ahead of the public subscription window. The allotment is expected to be finalised on June 10, 2026, with a tentative listing scheduled for June 12, 2026, on both the stock exchanges (NSE and BSE).

Investor reservation category

The issue has been structured with up to 50 per cent reserved for Qualified Institutional Buyers (QIBs), not less than 35 per cent for retail investors, and at least 15 per cent for Non-Institutional Investors (NIIs).

Lead manager and registrar of the issue

The book running lead managers for the issue are Cumulative Capital Pvt Ltd and Catalyst Capital Partners Private Limited, while the registrar of the issue is Kfin Technologies Ltd.

About Hexagon Nutrition

Founded in 1993, Hexagon Nutrition Ltd is a nutrition-focused company engaged in micronutrient premixes, clinical nutrition, therapeutic formulations, and ready-to-use foods. Its portfolio includes brands such as Pentasure, Obesigo, Pediagold, and Nutrone.

The company operates manufacturing facilities in Nasik, Chennai, and Thoothukudi in India, along with an overseas unit in Uzbekistan. It also exports to more than 75 countries and maintains a distribution network across pharmacies, hospitals, e-commerce platforms, and online pharmacies.

With dedicated R&D centres in Nasik and Chennai, supported by a specialised team of professionals, the company continues to focus on nutrition innovation and global expansion.